PubMed:17623048 / 393-513
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T57 | 29-34 | PR:Q5S006 | denotes | LRRK2 |
T58 | 29-34 | PR:000003033 | denotes | LRRK2 |
T59 | 29-34 | PR:Q5S007 | denotes | LRRK2 |
T60 | 44-59 | GO:0016301 | denotes | kinase activity |
T61 | 114-119 | PR:Q5S006 | denotes | LRRK2 |
T62 | 114-119 | PR:000003033 | denotes | LRRK2 |
T63 | 114-119 | PR:Q5S007 | denotes | LRRK2 |
PMID_GLOBAL
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T9 | 89-91 | DiseaseOrPhenotypicFeature | denotes | PD | 0008199|0015873|0005180 |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-120 | DRI_Background | denotes | Emerging evidence shows that LRRK2 contains kinase activity which is enhanced in several PD-associated mutants of LRRK2. |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T3 | 0-120 | DRI_Background | denotes | Emerging evidence shows that LRRK2 contains kinase activity which is enhanced in several PD-associated mutants of LRRK2. |